These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 17725897)

  • 21. Functional magnetic resonance imaging in neurology.
    Auer T; Schwarcz A; Horváth RA; Barsi P; Janszky J
    Ideggyogy Sz; 2008 Jan; 61(1-2):16-23. PubMed ID: 18372771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disturbed function and plasticity in multiple sclerosis as gleaned from functional magnetic resonance imaging.
    Filippi M; Rocca MA
    Curr Opin Neurol; 2003 Jun; 16(3):275-82. PubMed ID: 12858062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward a better understanding of cerebral plasticity in multiple sclerosis.
    Rocca MA; Filippi M
    J Neurol Sci; 2006 May; 244(1-2):1-2. PubMed ID: 16451805
    [No Abstract]   [Full Text] [Related]  

  • 24. Picturing multiple sclerosis: conventional and diffusion tensor imaging.
    Fox RJ
    Semin Neurol; 2008 Sep; 28(4):453-66. PubMed ID: 18843574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox?
    Strasser-Fuchs S; Enzinger C; Ropele S; Wallner M; Fazekas F
    Mult Scler; 2008 Mar; 14(2):205-11. PubMed ID: 17986507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tactile-associated recruitment of the cervical cord is altered in patients with multiple sclerosis.
    Agosta F; Valsasina P; Caputo D; Stroman PW; Filippi M
    Neuroimage; 2008 Feb; 39(4):1542-8. PubMed ID: 18061484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and imaging metrics for monitoring disease progression in patients with multiple sclerosis.
    Bagnato F; Ohayon JM; Ehrmantraut M; Chiu AW; Riva M; Ikonomidou VN
    Expert Rev Neurother; 2006 Apr; 6(4):599-612. PubMed ID: 16623658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy-induced plasticity of cognitive functions in MS patients: insights from fMRI.
    Penner IK; Kappos L; Rausch M; Opwis K; Radü EW
    J Physiol Paris; 2006 Jun; 99(4-6):455-62. PubMed ID: 16713204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
    Rovira A; León A
    Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging and degree of disability in multiple sclerosis.
    Kiel MK; Greenspun B; Grossman RI
    Arch Phys Med Rehabil; 1988 Jan; 69(1):11-3. PubMed ID: 3337635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional MR imaging in multiple sclerosis.
    Filippi M; Rocca MA
    Neuroimaging Clin N Am; 2009 Feb; 19(1):59-70. PubMed ID: 19064200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetization transfer MRI in multiple sclerosis.
    Filippi M; Agosta F
    J Neuroimaging; 2007 Apr; 17 Suppl 1():22S-26S. PubMed ID: 17425730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive deficits in multiple sclerosis: a review of functional MRI studies.
    Caramia F; Tinelli E; Francia A; Pozzilli C
    Neurol Sci; 2010 Nov; 31(Suppl 2):S239-43. PubMed ID: 20694492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on the relationships between neuropsychological dysfunction and structural MRI in multiple sclerosis.
    Tekok-Kilic A; Benedict RH; Zivadinov R
    Expert Rev Neurother; 2006 Mar; 6(3):323-31. PubMed ID: 16533137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?
    Goodin DS
    Ann Neurol; 2006 Apr; 59(4):597-605. PubMed ID: 16566022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance imaging in multiple sclerosis: the role of conventional imaging.
    Sicotte NL
    Neurol Clin; 2011 May; 29(2):343-56. PubMed ID: 21439445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multiple sclerosis. Clinical topodiagnosis in comparison with cerebral MRI findings].
    Baum K; Junge M; Felix R
    Nervenarzt; 1994 Aug; 65(8):542-8. PubMed ID: 7969651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive changes in multiple sclerosis.
    Amato MP; Zipoli V; Portaccio E
    Expert Rev Neurother; 2008 Oct; 8(10):1585-96. PubMed ID: 18928350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.